Ultrasound-guided microwave ablation for abdominal wall metastatic tumors: A preliminary study

Table 1 Patient and tumor characteristics

No.	Age (yr)	Sex	Tumor type	Tumor number	Tumor size (cm)	Antenna	Antenna number	Ablation power (W)	Ablation time (min)	Session	Follow up (mo)
1	59	M	HCC	1	1.8	T11	1	50	6	1	31
2	35	M	HCC	1	2.1	T11	1	50	8	1	26
3	68	M	HCC	2	4.3	T11	2	40	5	2	19
					4.8	T11	2	50	16.5	1	19
4	57	F	Ovary serous papillary adenocarcinoma	1	2.2	T7/T11	2	45	2	2	18
5	55	F	Lung adenocarcinomas	2	1.3	T11	1	50	3.5	1	18
					1.7	T11	1	50	3.5	1	18
6	56	F	Adrenocortical carcinoma	4	4	T11	2	60	12	1	9
					3.1	T11	2	30	12	1	9
					3.3	T7/T11	2	30	16	1	9
					2.5	T5	2	50	5	1	9
7	58	M	HCC	1	1.3	T11	2	50	5	1	3
8	48	M	Bladder adenocarcinoma	2	5	T11	2	40	15	2	13
					2.1	T11	2	50	11.8	1	13
9	59	F	Renal clear cell carcinoma	5	2.2	T11	2	60	5	1	15
					2.1	T11	2	50	5.5	1	15
					2.1	T11	2	50	6	1	15
					2	T7/T11	2	45	4	1	15
					1.6	T11	1	45	3.8	1	15
10	58	F	HCC	1	2.6	T5	1	50	13	1	1
11	42	M	Adrenal pheochromocytoma	3	3.1	T7	1	50	8	1	4
					2.8	T5	2	50	6.5	1	4
					1.4	T5	1	50	1.2	1	4

M: Male; F: Female; HCC: Hepatocellular carcinoma.